Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Sexually Transmitted Diseases
|
November 7, 2003
Core group evolution over time: high-risk sexual behavior in a birth cohort between sexual debut and age 26
Olivier Humblet, Charlotte Paul, Nigel Dickson
BMC Medical Research Methodology
|
August 24, 2023
Considerations for pooling real-world data as a comparator cohort to a single arm trial: a simulation study on assessment of heterogeneity
Daniel Backenroth, Trevor Royce, Jose Pinheiro, et al.
BMC Medical Research Methodology
|
October 25, 2021
Bayesian additional evidence for decision making under small sample uncertainty
Arjun Sondhi, Brian Segal, Jeremy Snider, et al.
Big Data
|
July 22, 2016
Big Data and Disease Prevention: From Quantified Self to Quantified Communities
Meredith A Barrett, Olivier Humblet, Robert A Hiatt, et al.
Environmental Health Perspectives
|
December 6, 2008
Dioxins and cardiovascular disease mortality
Olivier Humblet, Linda Birnbaum, Eric Rimm, et al.
British Journal of Medicine and Medical Research
|
September 21, 2012
Use of Specific IgE and Skin Prick Test to Determine Clinical Reaction Severity
Von Ta, Brittany Weldon, Grace Yu, et al.
Environmental Health Perspectives
|
June 7, 2014
Perfluoroalkyl chemicals and asthma among children 12-19 years of age: NHANES (1999-2008)
Olivier Humblet, Ledif Grisell Diaz-Ramirez, John R Balmes, et al.
Frontiers in Pharmacology
|
February 12, 2024
Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting
Letizia Polito, Qixing Liang, Navdeep Pal, et al.
Cancer
|
May 16, 2007
Environmental pollutants and breast cancer: epidemiologic studies
Julia Green Brody, Kirsten B Moysich, Olivier Humblet, et al.
Plos One
|
August 8, 2022
Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors
Derrek P Hibar, George D Demetri, Solange Peters, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Sexually Transmitted Diseases
|
November 7, 2003
Core group evolution over time: high-risk sexual behavior in a birth cohort between sexual debut and age 26
Olivier Humblet, Charlotte Paul, Nigel Dickson
BMC Medical Research Methodology
|
August 24, 2023
Considerations for pooling real-world data as a comparator cohort to a single arm trial: a simulation study on assessment of heterogeneity
Daniel Backenroth, Trevor Royce, Jose Pinheiro, et al.
BMC Medical Research Methodology
|
October 25, 2021
Bayesian additional evidence for decision making under small sample uncertainty
Arjun Sondhi, Brian Segal, Jeremy Snider, et al.
Big Data
|
July 22, 2016
Big Data and Disease Prevention: From Quantified Self to Quantified Communities
Meredith A Barrett, Olivier Humblet, Robert A Hiatt, et al.
Environmental Health Perspectives
|
December 6, 2008
Dioxins and cardiovascular disease mortality
Olivier Humblet, Linda Birnbaum, Eric Rimm, et al.
British Journal of Medicine and Medical Research
|
September 21, 2012
Use of Specific IgE and Skin Prick Test to Determine Clinical Reaction Severity
Von Ta, Brittany Weldon, Grace Yu, et al.
Environmental Health Perspectives
|
June 7, 2014
Perfluoroalkyl chemicals and asthma among children 12-19 years of age: NHANES (1999-2008)
Olivier Humblet, Ledif Grisell Diaz-Ramirez, John R Balmes, et al.
Frontiers in Pharmacology
|
February 12, 2024
Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting
Letizia Polito, Qixing Liang, Navdeep Pal, et al.
Cancer
|
May 16, 2007
Environmental pollutants and breast cancer: epidemiologic studies
Julia Green Brody, Kirsten B Moysich, Olivier Humblet, et al.
Plos One
|
August 8, 2022
Real-world survival outcomes in patients with locally advanced or metastatic NTRK fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors
Derrek P Hibar, George D Demetri, Solange Peters, et al.
Page
of 3